Lamivudine resistance and exacerbation of hepatitis B in infliximab-treated Crohn's disease patient

Inflamm Bowel Dis. 2007 Nov;13(11):1450-1. doi: 10.1002/ibd.20202.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / analysis*
  • Antibodies, Monoclonal / therapeutic use
  • Crohn Disease / complications*
  • Crohn Disease / drug therapy*
  • Drug Resistance*
  • Follow-Up Studies
  • Hepatitis B / chemically induced*
  • Hepatitis B / drug therapy
  • Humans
  • Infliximab
  • Lamivudine*
  • Male
  • Practice Guidelines as Topic
  • Virus Activation

Substances

  • Antibodies, Monoclonal
  • Lamivudine
  • Infliximab